ZIVAX Diagnostics, Inc. (NYSE MKT: IVD), a fully integrated in vitro diagnostics company, announced today that its corporate name has been changed to "ERBA Diagnostics, Inc...
IVAX Diagnostics, Inc. (NYSE Amex: IVD), a fully integrated in vitro diagnostics company, reports its financial results for the quarter ended March 31, 2012. Kevin D...
IVAX Diagnostics, Inc. (NYSE Amex: IVD), a fully integrated in vitro diagnostics company, reports its financial results for the fourth quarter and full year ended December 31...
IVAX Diagnostics, Inc. (NYSE Amex:IVD), a fully integrated in vitro diagnostics company, announced today that it has entered into an Amendment to that certain Stock Purchase...
IVAX Diagnostics, Inc. (NYSE Amex: IVD), a fully integrated in vitro diagnostics company, reports its financial results for the quarter and nine months ended September 30...
IVAX Diagnostics, Inc. (NYSE Amex:IVD), a fully integrated in vitro diagnostics company, reports its financial results for the quarter ended June 30, 2011. Kevin D. Clark...
IVAX Diagnostics, Inc. (NYSE Amex:IVD), a fully integrated in vitro diagnostics company, announced that its wholly-owned subsidiary – Diamedix Corporation – is participating as...
IVAX Diagnostics, Inc. (NYSE Amex:IVD), a fully integrated in vitro diagnostics company, announced that Diamedix Corporation, IVAX Diagnostics’ wholly-owned subsidiary located...
IVAX Diagnostics, Inc. (NYSE Amex:IVD), a fully integrated in vitro diagnostics company, announced that its three wholly-owned subsidiaries – Diamedix Corporation, ImmunoVision...
IVAX Diagnostics, Inc. (NYSE Amex: IVD), a fully integrated in vitro diagnostics company, announced today that it has consummated the initial transactions contemplated by its...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
Symbol | Price | Vol. |
---|---|---|
AAPYKurv Yield Premium Strategy Apple AAPL ETF | $ 27.098 (0.00%) | 0 |
AAPXT Rex 2X Long Apple Daily Target ETF | $ 32.68 (0.00%) | 0 |
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026 | $ 26.2001 (0.00%) | 0 |
AAAUGoldman Sachs Physical Gold ETF Shares | $ 26.31 (0.00%) | 0 |
AAAAlternative Access First Priority CLO Bond ETF | $ 25.085 (0.00%) | 0 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.